JP2021513552A5 - - Google Patents
Info
- Publication number
- JP2021513552A5 JP2021513552A5 JP2020543742A JP2020543742A JP2021513552A5 JP 2021513552 A5 JP2021513552 A5 JP 2021513552A5 JP 2020543742 A JP2020543742 A JP 2020543742A JP 2020543742 A JP2020543742 A JP 2020543742A JP 2021513552 A5 JP2021513552 A5 JP 2021513552A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- drug
- ibutamorene
- ghs
- Prior art date
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023221157A JP2024028337A (ja) | 2018-02-14 | 2023-12-27 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
| JP2025129927A JP2025179056A (ja) | 2018-02-14 | 2025-08-04 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630361P | 2018-02-14 | 2018-02-14 | |
| US62/630,361 | 2018-02-14 | ||
| PCT/US2019/017964 WO2019161025A1 (en) | 2018-02-14 | 2019-02-14 | Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023221157A Division JP2024028337A (ja) | 2018-02-14 | 2023-12-27 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513552A JP2021513552A (ja) | 2021-05-27 |
| JP2021513552A5 true JP2021513552A5 (https=) | 2022-02-21 |
| JPWO2019161025A5 JPWO2019161025A5 (https=) | 2022-02-21 |
Family
ID=67620042
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543742A Withdrawn JP2021513552A (ja) | 2018-02-14 | 2019-02-14 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
| JP2023221157A Pending JP2024028337A (ja) | 2018-02-14 | 2023-12-27 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
| JP2025129927A Pending JP2025179056A (ja) | 2018-02-14 | 2025-08-04 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023221157A Pending JP2024028337A (ja) | 2018-02-14 | 2023-12-27 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
| JP2025129927A Pending JP2025179056A (ja) | 2018-02-14 | 2025-08-04 | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の治療のための組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20210059993A1 (https=) |
| EP (3) | EP4623929A3 (https=) |
| JP (3) | JP2021513552A (https=) |
| KR (2) | KR20200121308A (https=) |
| CN (2) | CN118453597A (https=) |
| AU (2) | AU2019222736B2 (https=) |
| BR (1) | BR112020016613A2 (https=) |
| CA (1) | CA3088177A1 (https=) |
| EA (1) | EA202091464A1 (https=) |
| WO (1) | WO2019161025A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113646327A (zh) * | 2019-03-29 | 2021-11-12 | 综合医院公司 | 用于治疗肝脏疾病的ghrh或其类似物 |
| WO2022059946A1 (ko) * | 2020-09-18 | 2022-03-24 | 서울대학교 산학협력단 | 비알코올성 지방간염 및 간 섬유화의 치료를 위한 약학적 조성물 |
| KR20220132312A (ko) | 2021-03-23 | 2022-09-30 | 한국과학기술원 | 간세포의 IFN-γR1 매개 지질생성작용 억제를 통한 비알코올성 지방간 질환의 치료 방법 |
| KR20250107210A (ko) * | 2022-11-03 | 2025-07-11 | 루모스 파마, 인크. | 이부타모렌의 압축형 경구 제형 |
| WO2025193784A1 (en) * | 2024-03-12 | 2025-09-18 | Lumos Pharma, Inc. | Pharmaceutical formulations for maintaining lean muscle mass during weight loss treatment |
| WO2025217521A1 (en) * | 2024-04-12 | 2025-10-16 | Jnana Therapeutics Inc. | Treating chronic kidney disease with a combination of a slc6a19 inhibitor and a glp-1 agonist |
| CN119405782A (zh) * | 2025-01-06 | 2025-02-11 | 山东大学 | 胰岛素样生长因子结合蛋白-1在制备治疗非酒精性脂肪性肝病药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| US20070123470A1 (en) * | 2003-10-24 | 2007-05-31 | Wladimir Hogenhuis | Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue |
| JP2007532495A (ja) * | 2004-04-07 | 2007-11-15 | ガストロテック・ファルマ・アクティーゼルスカブ | グレリン欠乏を治療するための分泌促進薬の使用 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| US20090312302A1 (en) * | 2008-06-17 | 2009-12-17 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders |
| BR112017004708A2 (pt) * | 2014-09-12 | 2017-12-05 | Tobira Therapeutics Inc | terapia de combinação de cenicriviroc para o tratamento de fibrose |
| US20180360846A1 (en) * | 2015-09-16 | 2018-12-20 | Tobira Therapeutics, Inc. | Cenicriviroc combination therapy for the treatment of fibrosis |
| WO2019008554A1 (en) * | 2017-07-06 | 2019-01-10 | Conte Anthony | METHOD FOR ORAL TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE |
-
2019
- 2019-02-14 KR KR1020207023368A patent/KR20200121308A/ko not_active Ceased
- 2019-02-14 EP EP25195764.3A patent/EP4623929A3/en active Pending
- 2019-02-14 CN CN202410528969.XA patent/CN118453597A/zh active Pending
- 2019-02-14 EP EP19755124.5A patent/EP3781158A4/en not_active Ceased
- 2019-02-14 EP EP24205490.6A patent/EP4467158A3/en not_active Withdrawn
- 2019-02-14 CA CA3088177A patent/CA3088177A1/en active Pending
- 2019-02-14 BR BR112020016613-8A patent/BR112020016613A2/pt unknown
- 2019-02-14 KR KR1020247002905A patent/KR20240015742A/ko not_active Ceased
- 2019-02-14 AU AU2019222736A patent/AU2019222736B2/en active Active
- 2019-02-14 EA EA202091464A patent/EA202091464A1/ru unknown
- 2019-02-14 CN CN201980013533.4A patent/CN111727041A/zh active Pending
- 2019-02-14 WO PCT/US2019/017964 patent/WO2019161025A1/en not_active Ceased
- 2019-02-14 US US16/961,564 patent/US20210059993A1/en not_active Abandoned
- 2019-02-14 JP JP2020543742A patent/JP2021513552A/ja not_active Withdrawn
-
2023
- 2023-08-09 US US18/231,977 patent/US20230381158A1/en not_active Abandoned
- 2023-12-27 JP JP2023221157A patent/JP2024028337A/ja active Pending
-
2024
- 2024-08-07 AU AU2024205599A patent/AU2024205599A1/en active Pending
-
2025
- 2025-05-27 US US19/219,112 patent/US20250281470A1/en active Pending
- 2025-08-04 JP JP2025129927A patent/JP2025179056A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513552A5 (https=) | ||
| US11938124B2 (en) | Combination therapy for treatment of cancer | |
| CN101374523B (zh) | 用于治疗糖尿病的二肽基肽酶抑制剂 | |
| JP5827706B2 (ja) | 併用療法においてヒストンデアセチラーゼ阻害剤を使用し、バイオマーカーをモニタする方法 | |
| TWI412366B (zh) | 二肽基肽酶抑制劑之週投與方法 | |
| RU2384333C2 (ru) | Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин | |
| NO342004B1 (no) | 2-[6-(3-amino-piperidin-1-yl)-3-metyl-2,4-diokso-3,4-dihydro-2H-pyrimidin-1-ylmetyl]-4-fluor-benzonitril for anvendelse som et medikament for behandling av diabetes, cancer, en autoimmun sykdom eller HIV infeksjon | |
| US11357777B2 (en) | Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH) | |
| TWI842924B (zh) | Gpr119致效劑及dpp-4抑制劑的藥物組合及藥物套組 | |
| TW200932249A (en) | Combination therapy comprising SGLT inhibitors and DPP4 inhibitors | |
| AU2022308121B2 (en) | Combination therapy for treatment of liver diseases | |
| RU2020109881A (ru) | Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита | |
| TW201208702A (en) | Combination therapy for treating cancer comprising an IGF-1R inhibitor and an Akt inhibitor | |
| JP2018519340A5 (https=) | ||
| JP2021522247A5 (https=) | ||
| CN110637022A (zh) | 可作为流感病毒复制抑制剂的吡咯并嘧啶衍生物 | |
| JPWO2019161025A5 (https=) | ||
| JP2023507364A (ja) | インテグリン阻害剤を使用する肝疾患の治療の組み合わせ | |
| TWI845975B (zh) | 用於治療肝臟疾病的聯合治療 | |
| JP2005503391A5 (https=) | ||
| RU2818562C2 (ru) | Комбинированная терапия агонистами gpr119 и ингибиторами dpp-4 | |
| US20250367218A1 (en) | Methods of treating metabolic disorders and combination products for use in the same | |
| US20230028715A1 (en) | Il-31 modulators for treating fxr-induced pruritis | |
| JP2019524860A5 (https=) | ||
| RU2022104049A (ru) | Комбинированное лечение заболеваний печени агонистами fxr |